{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:57:46Z","timestamp":1794023866294,"version":"4.8.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fujian Provincial Natural Science Foundation of China","award":["2024J011474"],"award-info":[{"award-number":["2024J011474"]}]},{"name":"Research Funds of Centre for Leading Medicine and Advanced Technologies of IHM","award":["2023IHM01052"],"award-info":[{"award-number":["2023IHM01052"]}]},{"name":"the Science and Technology Program of Guangzhou, China","award":["2024B03J0436"],"award-info":[{"award-number":["2024B03J0436"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-25758-7","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T03:15:46Z","timestamp":1764818146000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Global and regional trends in psoriasis burden (1990\u20132021): age patterns and socio-demographic associations"],"prefix":"10.1186","volume":"26","author":[{"given":"Shunsheng","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0780-6747","authenticated-orcid":false,"given":"Tingjing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0705-1970","authenticated-orcid":false,"given":"Zhi-Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"25758_CR1","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1401a65","author":"F Tamer","year":"2024","unstructured":"Tamer F, Edek YC, Aksakal AB. Effect of treatment with biologic agents on the novel inflammatory biomarkers systemic immune inflammation index and systemic inflammation response index for psoriasis. Dermatol Pract Concept. 2024;14(1):e2024065. https:\/\/doi.org\/10.5826\/dpc.1401a65.","journal-title":"Dermatol Pract Concept"},{"issue":"6","key":"25758_CR2","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.jid.2022.11.021","volume":"143","author":"G Lada","year":"2023","unstructured":"Lada G, Chinoy H, Talbot PS, Warren RB, Kleyn CE. The relationship of depression and systemic inflammation in psoriasis: findings from the UK biobank. J Invest Dermatol. 2023;143(6):1091\u2013e42.","journal-title":"J Invest Dermatol"},{"key":"25758_CR3","doi-asserted-by":"publisher","first-page":"1323174","DOI":"10.3389\/fimmu.2024.1323174","volume":"15","author":"R Ma","year":"2024","unstructured":"Ma R, Cui L, Cai J, Yang N, Wang Y, Chen Q, et al. Association between systemic immune inflammation index, systemic inflammation response index and adult psoriasis: evidence from NHANES. Front Immunol. 2024;15:1323174.","journal-title":"Front Immunol"},{"issue":"5","key":"25758_CR4","doi-asserted-by":"publisher","first-page":"e586","DOI":"10.1111\/jdv.18860","volume":"37","author":"A Kvist-Hansen","year":"2023","unstructured":"Kvist-Hansen A, Kaiser H, Krakauer M, G\u00f8rtz PM, Wang X, Becker C, et al. Neutrophil-to-lymphocyte ratio and the systemic immune-inflammation index as potential biomarkers of effective treatment and subclinical atherosclerotic cardiovascular disease in patients with psoriasis. J Eur Acad Dermatol Venereol. 2023;37(5):e586-9.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"25758_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2021.100211","volume":"7","author":"W Zhou","year":"2021","unstructured":"Zhou W, Teklu M, Bui V, Manyak GA, Kapoor P, Dey AK, et al. The relationship between systemic inflammation and increased left ventricular mass is partly mediated by noncalcified coronary artery disease burden in psoriasis. Am J Prev Cardiol. 2021;7:100211.","journal-title":"Am J Prev Cardiol"},{"issue":"1","key":"25758_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaad.2020.04.139","volume":"84","author":"S Mehrmal","year":"2021","unstructured":"Mehrmal S, Uppal P, Nedley N, Giesey RL, Delost GR. The global, regional, and national burden of psoriasis in 195 countries and territories, 1990 to 2017: a systematic analysis from the global burden of disease study 2017. J Am Acad Dermatol. 2021;84(1):46\u201352.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"25758_CR7","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jid.2020.07.012","volume":"141","author":"D Verma","year":"2021","unstructured":"Verma D, Fekri SZ, Sigurdardottir G, Bivik Eding C, Sandin C, Enerb\u00e4ck C. Enhanced inflammasome activity in patients with psoriasis promotes systemic inflammation. J Invest Dermatol. 2021;141(3):586-95.e5.","journal-title":"J Invest Dermatol"},{"issue":"7","key":"25758_CR8","doi-asserted-by":"publisher","first-page":"e837","DOI":"10.1111\/jdv.18895","volume":"37","author":"T Gambichler","year":"2023","unstructured":"Gambichler T, W\u00fcrfel L, Abu Rached N, Mansour R, Bechara FG, Scheel CH. Systemic immune-inflammation biomarkers in psoriasis patients under Interleukin 17A-inhibitor treatment. J Eur Acad Dermatol Venereol. 2023;37(7):e837\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"25758_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112713","volume":"42","author":"K Sonomoto","year":"2023","unstructured":"Sonomoto K, Song R, Eriksson D, Hahn AM, Meng X, Lyu P, et al. High-fat-diet-associated intestinal microbiota exacerbates psoriasis-like inflammation by enhancing systemic \u03b3\u03b4 T cell IL-17 production. Cell Rep. 2023;42(7):112713.","journal-title":"Cell Rep"},{"issue":"10440","key":"25758_CR10","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"GBD Diseases","year":"2024","unstructured":"Diseases GBD, Injuries C. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):2133\u201361.","journal-title":"Lancet"},{"issue":"10440","key":"25758_CR11","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/S0140-6736(24)00812-2","volume":"403","author":"ZJ Ward","year":"2024","unstructured":"Ward ZJ, Goldie SJ. Global burden of disease study 2021 estimates: implications for health policy and research. Lancet. 2024;403(10440):1958\u20139.","journal-title":"Lancet"},{"issue":"1","key":"25758_CR12","doi-asserted-by":"publisher","first-page":"13325","DOI":"10.1038\/s41598-023-40595-7","volume":"13","author":"J Shu","year":"2023","unstructured":"Shu J, Jin W. Prioritizing non-communicable diseases in the post-pandemic era based on a comprehensive analysis of the GBD 2019 from 1990 to 2019. Sci Rep. 2023;13(1):13325.","journal-title":"Sci Rep"},{"issue":"1","key":"25758_CR13","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1186\/s12889-024-19923-7","volume":"24","author":"L Xu","year":"2024","unstructured":"Xu L, Wang Z, Wu W, Li M, Li Q. Global, regional, and national burden of intracerebral hemorrhage and its attributable risk factors from 1990 to 2021: results from the 2021 global burden of disease study. BMC Public Health. 2024;24(1):2426.","journal-title":"BMC Public Health"},{"issue":"1","key":"25758_CR14","doi-asserted-by":"publisher","first-page":"21750","DOI":"10.1038\/s41598-021-01188-4","volume":"11","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhu N, Li Z, Xie X, Liu T, Ouyang G. The global burden of decubitus ulcers from 1990 to 2019. Sci Rep. 2021;11(1):21750.","journal-title":"Sci Rep"},{"key":"25758_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103450","author":"F Cao","year":"2023","unstructured":"Cao F, He Y-S, Sang N, Liu Y-C, Hu X, Ni Q-Y, et al. Age-standardized incidence, prevalence, and mortality rates of autoimmune diseases in women of childbearing age from 1990 to 2019. Autoimmun Rev. 2023. https:\/\/doi.org\/10.1016\/j.autrev.2023.103450.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"25758_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40806-0","volume":"9","author":"I Dragomirescu","year":"2019","unstructured":"Dragomirescu I, Llorca J, Gomez-Acebo I, Dierssen-Sotos T. A join point regression analysis of trends in mortality due to osteoporosis in Spain. Sci Rep. 2019;9(1):4264.","journal-title":"Sci Rep"},{"issue":"4","key":"25758_CR17","doi-asserted-by":"publisher","first-page":"e003650","DOI":"10.1136\/rmdopen-2023-003650","volume":"9","author":"F Zhang","year":"2023","unstructured":"Zhang F, Cui Y, Gao X. Time trends in the burden of autoimmune diseases across the BRICS: an age\u2013period\u2013cohort analysis for the GBD 2019. RMD Open. 2023;9(4):e003650.","journal-title":"RMD Open"},{"key":"25758_CR18","doi-asserted-by":"crossref","unstructured":"Cui Y, Yan Y. Time Trends in the Burden of Autoimmune Diseases Across the BRICS: An Age-Period-Cohort Analysis for the GBD. 2019;9(4):e003650. Available at SSRN 4561067.","DOI":"10.1136\/rmdopen-2023-003650"},{"key":"25758_CR19","doi-asserted-by":"publisher","first-page":"861053","DOI":"10.3389\/fcimb.2022.861053","volume":"12","author":"Y Xue","year":"2022","unstructured":"Xue Y, Bao W, Zhou J, Zhao QL, Hong SZ, Ren J, et al. Global burden, incidence and disability-adjusted life-years for dermatitis: a systematic analysis combined with socioeconomic development status, 1990\u20132019. Front Cell Infect Microbiol. 2022;12:861053.","journal-title":"Front Cell Infect Microbiol"},{"key":"25758_CR20","unstructured":"Burden-Teh E. Improving our Understanding of childhood psoriasis: identifying opportunities for early intervention for the prevention of long-term harm. University of Nottingham; 2020. Available from: https:\/\/eprints.nottingham.ac.uk\/61246\/."},{"issue":"4","key":"25758_CR21","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.jaad.2020.11.039","volume":"84","author":"J Burshtein","year":"2021","unstructured":"Burshtein J, Strunk A, Garg A. Incidence of psoriasis among adults in the United States: a sex-and age-adjusted population analysis. J Am Acad Dermatol. 2021;84(4):1023\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"25758_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.743180","volume":"8","author":"G Damiani","year":"2021","unstructured":"Damiani G, Bragazzi NL, Karimkhani Aksut C, Wu D, Alicandro G, McGonagle D, et al. The global, regional, and national burden of psoriasis: results and insights from the global burden of disease 2019 study. Front Med (Lausanne). 2021;8:743180.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"25758_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.47316\/cajmhe.2024.5.1.03","volume":"5","author":"O Al-Omoush","year":"2024","unstructured":"Al-Omoush O, HajAli M, Assaf M, Tarakhan H, Alzoubi A, Saleh O, et al. The burden of psoriasis across United States: findings from the 2019 global burden of diseases study and forecasts from 2025 to 2035. Central Asian Journal of Medical Hypotheses and Ethics. 2024;5(1):35\u201357.","journal-title":"Central Asian Journal of Medical Hypotheses and Ethics"},{"key":"25758_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003650","author":"F Zhang","year":"2023","unstructured":"Zhang F, Cui Y, Gao X. Time trends in the burden of autoimmune diseases across the BRICS: an age-period-cohort analysis for the GBD 2019. RMD Open. 2023. https:\/\/doi.org\/10.1136\/rmdopen-2023-003650.","journal-title":"RMD Open"},{"key":"25758_CR25","doi-asserted-by":"publisher","first-page":"m1590","DOI":"10.1136\/bmj.m1590","volume":"369","author":"R Parisi","year":"2020","unstructured":"Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020;369:m1590.","journal-title":"BMJ"},{"issue":"2","key":"25758_CR26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1684\/ejd.2022.4245","volume":"32","author":"Y Mou","year":"2022","unstructured":"Mou Y, Li F, Xu Y, Jin X, Dong S, Xia J. Global trends in the incidence of psoriasis from 1990 to 2019. Eur J Dermatol. 2022;32(2):207\u201313.","journal-title":"Eur J Dermatol"},{"issue":"6","key":"25758_CR27","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s40257-023-00807-2","volume":"24","author":"HM Wang","year":"2023","unstructured":"Wang HM, Xu JM, Jin HZ. Characteristics and burdens of disease in patients from Beijing with generalized pustular psoriasis and palmoplantar pustulosis: multicenter retrospective cohort study using a regional database. Am J Clin Dermatol. 2023;24(6):991\u20131002.","journal-title":"Am J Clin Dermatol"},{"key":"25758_CR28","doi-asserted-by":"crossref","unstructured":"Entringer TM, Stacherl B. [Loneliness in Germany-prevalence, development over time, and regional differences]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2024;67(10):1103\u201312.","DOI":"10.1007\/s00103-024-03937-y"},{"key":"25758_CR29","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.2147\/CCID.S393697","volume":"15","author":"Q Zheng","year":"2022","unstructured":"Zheng Q, Kuai L, Jiang W, Qiang Y, Wei L, Chen S, et al. Clinical feature, lifestyle behavior and non-communicable diseases comorbidities among psoriasis patients in Shanghai: gender disparity analysis based on a cross-sectional study. Clin Cosmet Investig Dermatol. 2022;15:2751\u201362.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"2","key":"25758_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.23950\/jcmk\/14497","volume":"21","author":"A Dairov","year":"2024","unstructured":"Dairov A, Issabekova A, Sekenova A, Shakhatbayev M, Ogay V. Prevalence, incidence, gender and age distribution, and economic burden of psoriasis worldwide and in Kazakhstan. J Clin Med Kaz. 2024;21(2):18\u201330.","journal-title":"J Clin Med Kaz"},{"issue":"2","key":"25758_CR31","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1111\/jdv.17656","volume":"36","author":"K Hansel","year":"2022","unstructured":"Hansel K, Zangrilli A, Bianchi L, Peris K, Chiricozzi A, Offidani A, et al. A 52-week update of a multicentre real-life experience on effectiveness and safety of risankizumab in psoriasis. J Eur Acad Dermatol Venereol. 2022;36(2):e111-3.","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25758-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-25758-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25758-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:03:38Z","timestamp":1767837818000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-025-25758-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["25758"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-25758-7","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"26 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study analyzed publicly available data from the Global Burden of Disease (GBD) database, containing no personally identifiable information. As per institutional guidelines for de-identified population health data, formal ethical approval was not required. All analyses were conducted in accordance with GBD data use agreements, relevant privacy protection regulations, and institutional data governance policies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}